• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: STIMWAVE TECHNOLOGIES INC. STIMQ NEUROSTIMULATOR; PERIPHERAL NEWRVE STIMULATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

STIMWAVE TECHNOLOGIES INC. STIMQ NEUROSTIMULATOR; PERIPHERAL NEWRVE STIMULATOR Back to Search Results
Model Number STQ4-RCV-A0
Device Problem Material Erosion (1214)
Patient Problems Skin Erosion (2075); Skin Inflammation/ Irritation (4545)
Event Date 02/11/2021
Event Type  Injury  
Manufacturer Narrative
The clinical representative instructed the patient to contact the implanting clinician's office to schedule a follow-up appointment.On (b)(6) 2021, the patient attended a follow-up appointment with the implanting clinician.During this visit, the implanting clinician determined the patient's leads had eroded, and the leads needed to be explanted.The implanting clinician decided to perform an explant procedure on (b)(6) 2021.The patient and the implanting clinician decided to re-implant the stimulator at a later time.The implanting clinician mentioned to the clinical representative that one of the contributing factors for the erosion taking place is the patient's poor skin quality.The clinical representative confirmed that the implant procedure was performed in a sterile environment with sterile field handling protocols, sterile barriers of all products used were intact before the implant, and the procedure was completed in accordance with the product instructions for use.A stimwave representative conducted a review of sterilization and packaging records for the respective product lot; stimwave has confirmed that the product was delivered sterile, validated sterilization parameters were used, and sterile barriers were verified to be intact following packaging.Based on this information, the erosion was confirmed/replicated.There is no evidence that the product did not meet specifications, and the stimulator is used to treat pain.The cause of the erosion is unknown/no problem found.Design fmea for stimq 06-01233 and hra for stimq 06-01232 was reviewed and erosion is a known issue with mitigation controls in place to reduce risk as far as possible and no corrective action is required.
 
Event Description
On (b)(6) 2021, the patient contacted the clinical representative to report that the leads had eroded through the skin.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STIMQ NEUROSTIMULATOR
Type of Device
PERIPHERAL NEWRVE STIMULATOR
Manufacturer (Section D)
STIMWAVE TECHNOLOGIES INC.
1310 park central boulevard s.
pompano beach FL 33064
Manufacturer (Section G)
STIMWAVE TECHNOLOGIES INC.
1310 park central boulevard s.
pompano beach FL 33064
Manufacturer Contact
andrea najera
1310 park central boulevard s.
pompano beach, FL 33064
8009655134
MDR Report Key11478673
MDR Text Key239662012
Report Number3010676138-2021-00043
Device Sequence Number1
Product Code GZF
UDI-Device Identifier00818225020464
UDI-Public010081822502046417221001
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K171366
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Other
Type of Report Initial
Report Date 02/11/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/13/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date10/01/2022
Device Model NumberSTQ4-RCV-A0
Device Lot NumberSWO201025
Was Device Available for Evaluation? No
Date Manufacturer Received01/12/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-